1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.21%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-11.62%
Negative gross profit growth while MAXN is at 73.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
-170.82%
Negative EBIT growth while MAXN is at 71.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-34.04%
Negative operating income growth while MAXN is at 66.50%. Joel Greenblatt would press for urgent turnaround measures.
-965.36%
Negative net income growth while MAXN stands at 73.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-920.00%
Negative EPS growth while MAXN is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1125.00%
Negative diluted EPS growth while MAXN is at 73.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.56%
Share change of 1.56% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-13.07%
Reduced diluted shares while MAXN is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
50.99%
OCF growth at 50-75% of MAXN's 93.92%. Martin Whitman would question if the firm lags in monetizing sales effectively.
33.16%
FCF growth under 50% of MAXN's 91.23%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
253.43%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-51.51%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-48.93%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-227.20%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-152.69%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-185.48%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-603.56%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-296.64%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1.15%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
254.46%
Positive growth while MAXN is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-24.80%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
19.02%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31.50%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
12.62%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.05%
Positive asset growth while MAXN is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.39%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
4.50%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
21.46%
R&D growth drastically higher vs. MAXN's 3.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.